Each filer's latest filing for 151190105 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
|
Bristol Myers Squibb Co
13G/A
|
1.9% |
2/14/2025
Event 12/31/2024
|
||
| Bristol Myers Squibb Co | 1.9% | |||
| Celgene Corporation | 1.9% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2024 Q1 | 1 | 10.0 k | $3.91k |
| 2023 Q4 | 39 | 8.28 M | $2.05M |
| 2023 Q3 | 48 | 36.3 M | $8.02M |
| 2023 Q2 | 58 | 35.3 M | $18.8M |
| 2023 Q1 | 64 | 34.3 M | $21.3M |
| 2022 Q4 | 77 | 34.3 M | $44.3M |
| 2022 Q3 | 75 | 35.1 M | $81.1M |
| 2022 Q2 | 75 | 30.9 M | $105M |
| 2022 Q1 | 45 | 26.6 M | $232M |
| 2021 Q4 | 29 | 16.7 M | $85.6M |
| 2021 Q3 | 27 | 1.19 M | $8.42M |